XML 59 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
Stock-based compensation for the years ended December 31, 2020, 2019, and 2018 includes expense related to awards of stock options, performance and service based restricted stock units and purchases under the 2010 Employee Stock Purchase Plan. Total stock-based compensation expense and the related income tax benefit were as follows:
Year Ended December 31,
202020192018
(In thousands)
Total stock-based compensation expense$53,694 $29,583 $50,093 
Related income tax benefit6,573 5,143 3,783 
Schedule of Stock Options and Restricted Stock Units Granted
The following table summarizes restricted stock units with only service conditions granted under our 2010 Equity Incentive Plan:
 Year Ended December 31,
 202020192018
(In thousands, except per share data)
Restricted stock units granted1,618 238 452 
Weighted-average grant-date fair value$31.12 $38.93 $74.33 
The following table summarizes the performance-based restricted stock units granted under our 2010 Equity Incentive Plan:
 Year Ended December 31,
 202020192018
(In thousands, except per share data)
Performance restricted stock units granted1,045 722 276 
Weighted-average grant-date fair value$33.15 $48.45 $71.70 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
Restricted stock unit activity for the year ended December 31, 2020 was as follows:
SharesWeighted-Average Grant-Date Fair Value
(In thousands, except per share data)
Outstanding at December 31, 2019
888 $47.20 
Restricted stock units granted1,618 31.12 
Restricted stock units vested(616)34.51 
Restricted stock units canceled(668)38.57 
Outstanding at December 31, 2020
1,222 $36.24 
Performance-based restricted stock unit activity for the year ended December 31, 2020 was as follows:
SharesWeighted-Average Grant-Date Fair Value
(In thousands, except per share data)
Outstanding at December 31, 2019
854 $54.63 
Performance restricted stock units granted (at target)1,045 $33.15 
Performance restricted stock units vested(258)$50.33 
Performance restricted stock units canceled(695)$48.72 
Outstanding at December 31, 2020
946 $35.62 
Schedule of Weighted-Average Assumptions Used to Estimate Stock Option Fair Value
The following table summarizes our market-based stock options granted:
 Year Ended December 31,
 2020
(In thousands, except per share data)
Stock options granted2,250 
Weighted-average exercise price$31.30 
Weighted-average grant-date fair value$14.57 

 Year Ended December 31,
 2020
Risk-free interest rate0.63 %
Expected term (in years)3.30
Expected dividends 
Expected volatility53.8 %
Schedule of Stock Option Activity
Total stock option activity for the year ended December 31, 2020 was as follows:
OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Life
(in Years)
Aggregate Intrinsic Value
(In thousands, except per share data and years)
Outstanding at December 31, 2019
181 $20.09 
Options granted2,250 31.30 
Options exercised(404)26.13 
Options canceled(393)28.37 
Outstanding at December 31, 2020
1,634 $32.04 5.99$38,836 
Exercisable at December 31, 2020
134 22.95 2.06$4,411